tradingkey.logo
tradingkey.logo
検索

Sanara Medtech Inc

SMTI
ウォッチリストに追加
24.840USD
+0.570+2.35%
終値 07/02, 13:00ET15分遅れの株価
227.66M時価総額
損失額直近12ヶ月PER

詳細情報 Sanara Medtech Inc 企業名

Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.

Sanara Medtech Incの企業情報

企業コードSMTI
会社名Sanara Medtech Inc
上場日Apr 07, 1994
最高経営責任者「CEO」Muppalla (Suresh V)
従業員数141
証券種類Ordinary Share
決算期末Apr 07
本社所在地1200 Summit Avenue
都市FORT WORTH
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号76102
電話番号18175292300
ウェブサイトhttps://sanaramedtech.com/
企業コードSMTI
上場日Apr 07, 1994
最高経営責任者「CEO」Muppalla (Suresh V)

Sanara Medtech Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%
Mr. Keith G. Myers
Mr. Keith G. Myers
Independent Director
Independent Director
9.32K
+47.02%
Mr. Suresh V. (Sam) Muppalla
Mr. Suresh V. (Sam) Muppalla
President and Chief Executive Officer of Tissue Health Plus, LLC
President and Chief Executive Officer of Tissue Health Plus, LLC
2.97K
--
Mr. Robert A. (Bob) DeSutter
Mr. Robert A. (Bob) DeSutter
Independent Director
Independent Director
--
--
Mr. Roszell Mack, III
Mr. Roszell Mack, III
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Seth D. Yon
Mr. Seth D. Yon
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
109.55K
-3.52%
Mr. Ronald T. (Ron) Nixon
Mr. Ronald T. (Ron) Nixon
Executive Chairman of the Board
Executive Chairman of the Board
68.20K
+6.09%
Ms. Ann Beal Salamone
Ms. Ann Beal Salamone
Director
Director
26.86K
+15.47%
Ms. Sara N. Ortwein
Ms. Sara N. Ortwein
Independent Director
Independent Director
25.41K
+18.16%
Mr. Eric D. Tanzberger
Mr. Eric D. Tanzberger
Independent Director
Independent Director
22.97K
+23.11%
Mr. Eric D. Major
Mr. Eric D. Major
Independent Director
Independent Director
14.23K
+34.05%

よくある質問

Sanara Medtech Incの上位5名の株主は誰ですか?

Sanara Medtech Incの上位5名の株主は以下のとおりです。Mr. Seth D. Yon

Sanara Medtech Inc(SMTI)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Sanara Medtech Incの株式を保有している機関は131社あり、保有株式の総市場価値は約1.42Mで、全体の15.50%を占めています。2025Q4と比較して、機関の持ち株は-599767.00増加しています。

Sanara Medtech Incの最大の収益源は何ですか?

2026Q1において、Soft tissue repair products部門がSanara Medtech Incにとって最大の収益を生み出しており、その金額は91.35Mで、全収益の88.59%を占めています。